Imago BioSciences   Report issue

For profit Phase 1 Phase 2
Founded: San Carlos CA United States (2012)

Organization Overview

First Clinical Trial
2016
NCT02842827
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Imago BioSciences,Inc.